[1] Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG;International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders[J]. Neurology, 2015, 85:177-189. [2] Freitas E, Guimar?es J. Neuromyelitis optica spectrum disorders associated with other autoimmune diseases[J]. Rheumatol Int, 2015, 35:243-253. [3] Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR, Harirchian MH, Asgari N, Naser Moghadasi A. Autoimmune diseases associated with neuromyelitis optica spectrum disorders:a literature review[J]. Mult Scler Relat Disord, 2019, 27:350-363. [4] Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schi?dt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, Daniels T;Sj?gren's International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sj?gren's syndrome:a data-driven, expert consensus approach in the Sj?ren's International Collaborative Clinical Alliance cohort[J]. Arthritis Care Res (Hoboken), 2012, 64:475-487. [5] Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G. 2010 Rheumatoid arthritis classification criteria:an American College of Rheumatology/European League against Rheumatism Collaborative Initiative[J]. Arthritis Rheum, 2010, 62:2569-2581. [6] Endocrinology Branch, Chinese Medical Association, Compiled group of the Guide for Diagnosis and Treatment of Thyroid Diseases. Guide for diagnosis and treatment of thyroid diseases in China:thyroiditis[J]. Zhonghua Nei Ke Za Zhi, 2008, 47:784-788.[中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南——甲状腺炎[J].中华内科杂志, 2008, 47:784-788.] [7] Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997, 40:1725. [8] Berkowitz AL, Samuels MA. The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis[J]. Pract Neurol, 2014, 14:14-22. [9] Carvalho DC, Tironi TS, Freitas DS, Kleinpaul R, Talim NC, Lana-Peixoto MA. Sj?gren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu[J].Arq Neuropsiquiatr, 2014, 72:619-624. [10] Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zéphir H, Moder K, Weinshenker BG. Neuromyelitis optica and non organ-specific autoimmunity[J]. Arch Neurol, 2008, 65:78-83. [11] Chai J, Logigian EL. Neurological manifestations of primary Sjogren's syndrome[J]. Curr Opin Neurol, 2010, 23:509-513. [12] Sá MJ. Acute transverse myelitis:a practical reappraisal[J].Autoimmun Rev, 2009, 9:128-131. [13] Qiao L, Luo Y, Zhang LL, Zhao LD, Wang Q, Xu Y, Zhao Y. The clinical characteristics of primary Sjogren syndrome with neuromyelitis optica[J]. Zhonghua Nei Ke Za Zhi, 2013, 52:745-748. [14] Lalji A, Izbudak I, Birnbaum J. Cortical blindness and not optic neuritis as a cause of vision loss in a Sj?gren's syndrome (SS) patient with the neuromyelitis optica spectrum disorder (NMOSD):challenges of ascribing demyelinating syndromes to SS:a case report[J]. Medicine (Baltimore), 2017, 96:e7454. [15] Sawada J, Orimoto R, Misu T, Katayama T, Aizawa H, Asanome A, Takahashi K, Saito T, Anei R, Kamada K, Miyokawa N, Takahashi T, Fujihara K, Hasebe N. A case of pathology-proven neuromyelitis optica spectrum disorder with Sj?gren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion[J]. Mult Scler, 2014, 20:1413-1416. [16] Park JH, Hwang J, Min JH, Kim BJ, Kang ES, Lee KH. Presence of anti-Ro/SSA antibody may be associated with antiaquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder[J]. J Neurol Sci, 2015, 348:132-135. [17] Masuda H, Mori M, Uzawa A, Muto M, Uchida T, Kuwabara S. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica[J]. Eur J Neurol, 2016, 23:276-281. [18] Zhong YH, Zhong ZG, Zhou Z, Ma ZY, Qiu MY, Peng FH, Zhang WX. Comparisons of presentations and outcomes of neuromyelitis optica patients with and without Sj?gren's syndrome[J]. Neurol Sci, 2017, 38:271-277. [19] Javed A, Balabanov R, Arnason BG, Kelly TJ, Sweiss NJ, Pytel P, Walsh R, Blair EA, Stemer A, Lazzaro M, Reder AT. Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis[J]. Mult Scler, 2008, 14:809-814. [20] Long Y, Liang J, Wu L, Lin S, Gao C, Chen X, Qiu W, Yang Y, Zheng X, Yang N, Gao M, Chen Y, Wang Z, Su Q. Different phenotypes at onset in neuromyelitis optica spectrum disorder patients with aquaporin-4 autoimmunity[J]. Front Neurol, 2017, 8:62. [21] Estiasari R, Matsushita T, Masaki K, Akiyama T, Yonekawa T, Isobe N, Kira J. Comparison of clinical, immunological and neuroimaging features between anti-aquaporin-4 antibody-positive and antibody-negative Sjogren's syndrome patients with central nervous system manifestations[J]. Mult Scler, 2012, 18:807-816. [22] Li H, Dai Y, Wu AM, Sun X, Lin Y, Lv K, Lu Z. Anti-thyroid antibodies and cerebrospinal fluid findings in neuromyelitis optica spectrum disorders[J]. J Neuroimmunol, 2015, 281:38-43. [23] Asgari N, Jarius S, Laustrup H, Skejoe HP, Lillevang ST, Weinshenker BG, Voss A. Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus:a predominantly population-based study[J]. Mult Scler, 2018, 24:331-339. [24] Zhang S, Wang Z, Zhao J, Wu DI, Li J, Wang Q, Su J, Xu D, Wang Y, Li M, Zeng X. Clinical features of transverse myelitis associated with systemic lupus erythematosus[J]. Lupus, 2020, 29:389-397. [25] Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis[J]. Ann Neurol, 2006, 59:566-569. [26] Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO:a study on antibody titre[J]. Brain, 2007, 130(Pt 5):1235-1243. |